Full-year 2020 revenue for SeaSpine declined 3 percent year over year to $154.3 million, according to the company's March 1 earnings report.
Five things to know:
1. Fourth-quarter revenue was $46.4 million, a 6.2 percent year-over-year increase.
2. Sales of new and recently launched products drove sales, making up 68 percent of total sales. The company's spinal implants and orthobiologics revenue made up the other 35 percent of sales.
3. Fourth-quarter international revenue decreased 3.2 percent to $4.3 million.
4. For the full year, SeaSpine reported U.S. revenues of $138.9 million, a 2.1 percent year-over-year decrease.
5. SeaSpine posted a net loss of $43.2 million for 2020, up from $39.3 million in 2019.
Keith Valentine, president and CEO of SeaSpine, said, "Despite all the uncertainty and disruption we faced in 2020, the entire SeaSpine organization remained committed to our mission to deliver cost effective spinal implants and orthobiologics procedural solutions to surgeons and hospitals to improve the quality of patient lives."